Home
Products
Learn
About
Pricing
Log In
IVX
Asset Logo

Invion Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

7
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for a variety of cancers, atherosclerosis and infectious diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. The company produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. The company is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).

📈 Performance

Price History

-91.33%

1M

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in IVX

7

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in IVX

1103 days
IVX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

27%

Less than 50k

64%
👶 Age of investors

18 - 25

29%

26 - 34

14%

35 - 90

57%
🙋 Legal gender of investors

Female

57%

Male

43%

Pearlers who invest in IVX also invest in...

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 446 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.

📊 Share price

$4.67 AUD

NULL RESOURCES

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

CRYP

CRYP.AX was created on 2021-11-02 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. CRYP.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to global companies at the forefront of the crypto economy.

📊 Share price

$2.75 AUD

Qantas Airways Ltd. provides air transportation services. The company is headquartered in Mascot, New South Wales. The firm is focused on the operation of international and domestic air transportation services, the provision of freight services, and the operation of a frequent flyer loyalty program. The firm's segments include Qantas Domestic, Qantas International, Jetstar Group and Qantas Loyalty. The Qantas Domestic, Qantas International, and Jetstar Group are engaged in passenger flying business and air cargo and express freight businesses. The Qantas Loyalty segment is engaged in the customer loyalty recognition programs. Its main business is the transportation of customers using two airline brands, which include Qantas and Jetstar. Its airline brands operate in regional, domestic and international services. The firm operates in Australia, New Zealand, South Pacific, Asia, Europe, North and South America, and Africa.

📊 Share price

$6.51 AUD

NULL AIRLINES

Magnis Energy Technologies Ltd. is engaged in the business of exploring, developing and mining natural flake graphite and manufacturing lithium-ion battey. The company is headquartered in Sydney, New South Wales and currently employs 7 full-time employees. The company went IPO on 2005-10-25. The firm supports and accelerates the adoption of electric vehicles and renewable energy storage critical for the green energy transition. The firm's subsidiary, Imperium3 New York, Inc (iM3NY), operates a Gigawatt scale Lithium-ion battery manufacturing project in Endicott, New York. The company also has a joint venture and lithium-ion research and development (R&D) technology partner, Charge CCCV LLC (C4V). iM3NY has commercialized C4Vs patented cathode chemistry to produce green credentialed lithium-ion battery cells for use in both electric vehicles and battery energy storage systems. The firm also has a 100% interest in the Nachu Project, which is a large-scale natural flake graphite project in Tanzania.

📊 Share price

$0.16 AUD

Want more shares? Try these...

IVXDA

📊 Share price

$38.79 AUD
Compare
Add to watchlist